Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion type Assertion NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_head.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion description "[A preferred panel would also include CD20, CD117, CD28 and CD27; 4) discrepancies between the percentage of plasma cells detected by flow cytometry and morphology are primarily related to sample quality and it is, therefore, important to determine that marrow elements are present in follow-up samples, particularly normal plasma cells in MRD negative cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_provenance.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion evidence source_evidence_literature NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_provenance.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion SIO_000772 18268286 NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_provenance.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion wasDerivedFrom befree-2016 NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_provenance.
- NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_assertion wasGeneratedBy ECO_0000203 NP654994.RAXTbZiPF-6lBNqWNHva1DxKHkEXOYzbRPZaJy-ZwBq_s130_provenance.